ESC: Novartis’ Entresto racks up a heart failure study win—but it’s a mixed one kblankenship Sat, 08/29/2020 – 17:17 More: ESC: Novartis' Entresto racks up a heart failure study win—but it's a mixed one Source: fierce
read moreESC: AstraZeneca’s Farxiga cuts kidney disease risks by 39% in trial that could ‘rewrite’ the treatment textbook kblankenship Sat, 08/29/2020 – 13:31 More: ESC: AstraZeneca's Farxiga cuts kidney disease risks by 39% in trial that could 'rewrite' the treatment textbook
read moreESC: Pfizer, BMS’ Eliquis tops Xarelto, vitamin K drugs for site-specific bleeding risks in French real-world study kblankenship Sat, 08/29/2020 – 12:26 More: ESC: Pfizer, BMS' Eliquis tops Xarelto, vitamin K drugs for site-specific bleeding risks in French real-world study
read more© 1994 - 2026 B.M. Pharmaceuticals